Djunda Ratenan-Peltier Awarded C3 Travel Grant

C3 is pleased to announce that Djunda Ratenan-Peltier was awarded a Travel Grant for the presentation of her research at the international conference New Directions in Biology and Disease of Skeletal Muscle, which took place from June 7 to 10, 2026 in Fort Lauderdale, Florida. Ms. Ratenan-Peltier is a PhD student in Life Sciences at Paris-Saclay University, conducting doctoral research at Généthon in the Progressive Muscular Dystrophies team led by Dr. Isabelle Richard.

Ms. Ratenan-Peltier’s poster presentation, titled “Combining a new Capn3-null rat model and machine-learning-driven muscle analysis to advance LGMD2A/R1 gene therapy evaluation,” describes work establishing a novel, physiologically relevant rat model of LGMD2A/R1. The researchers utilized machine-learning to analyze the muscle of the rat model, and demonstrated it can be used to test potential gene therapy vectors.

Watch the video description of this project which received a a Communication Award from conference organizers.


C3 awards Travel Grants to early career investigators who are currently conducting research in the areas of calpainopathies (LGMD2A/R1 and LGMDD4) so they can present their work at relevant conferences and meetings. For more information, visit our Grant Program page.

*Additional poster authors: Anthony Brureau, Carinne Roudaut, Marine Faivre, Axel Fressancourt, Michael Blatzer, Nathalie Danièle, Isabelle Richard | Généthon

Recent Posts

  • Dr. Levy to Present at First TREAT-NMD LGMD Masterclass in the US

    Advancing Excellence in LGMD Diagnosis, Care, and Emerging Therapies (CME Accreditation) 📅 13-14 November 2026 | 📍 Atlanta, Georgia As new therapies move closer to clinical practice, the need for accurate diagnosis, specialist knowledge, and coordinated multidisciplinary care has never been greater. Developed for healthcare professionals involved in the diagnosis and management of limb-girdle muscular... Read More
  • New Research Alert! "The Energy Switch"

    A new paper, “CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype,” was recently published in the journal Human Molecular Genetics. It was authored by a multi-institutional group led by Dr. Melissa Spencer, C3 Scientific Advisory Board Chair and Professor of Neurology and... Read More